The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study

This cross-sectional study, conducted at the Sindh Institute of Urology and Transplantation (SIUT), involved a retrospective data review of all the patients diagnosed with breast cancer from March 2017 to December 2021. The demographic characteristics, clinical presentation, stage of the disease, and histopathological characteristics were analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Cancer Invasive Breast Cancer Metastatic Breast Cancer Stage Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sindh Institute of Urology and Transplantation

Karachi, Sindh, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients diagnosed with breast cancer

Exclusion criteria

The patients that were lost to follow-up after the first consultation and those consulting for a second opinion were excluded from the study.

Treatment and study plan

Primary outcomes

Demographic characteristics of patients with breast cancer

Time frame: At the time of presentation

age, gender, residence, marital status
Risk factors of patients with breast cancer

Time frame: At the time of presentation

age at menarche, menopause, parity, breastfeeding, contraception, family history, body mass index
Clinical presentation of patients with breast cancer

Time frame: At the time of presentation

site and duration
Stage of the breast cancer

Time frame: At the time of presentation

American Joint Committee on Cancer (AJCC) Anatomic Stage Groups for breast cancer
Histopathological characteristics of patients with breast cancer

Time frame: At the time of presentation

tumor type, hormone receptor status, Ki-67, and grade

Sponsors and collaborators

Lead sponsor

Sindh Institute of Urology and Transplantation

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Jul 18, 2022
Registry last updated: Jul 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting